In line with literature data, REG3A associated with GI GvHD independently of cutaneous GvHD (Two-Way ANOVA p < 0.0001), and so did PI3 with cutaneous aGvHD independently of gut manifestations (Two-Way ANOVA p = 0.0058). This evidence concerns the gene REG3A and graft versus host disease.